TABLE I. Colony-Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 ± 4.6 Control 2 48.5 ± 14.1 Before chemotherapy 24.4 ± 6.2 b After chemotherapy 50.5 ± 6.5 Values are means ± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a pa
A novel four base-pair deletion within the A?-GLOBin gene promoter associated with slight increase of A? expression in adult
✍ Scribed by Huang, Xiao-Dong; Yang, Xuexian O.; Huang, Rui-Bin; Zhang, Hong-Yuan; Zhao, Hua-Lu; Zhao, Yan-Jun; Huang, Cheng-Le; Hou, Chun-Jiang; Zhang, Jun-Wu
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 70 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
We studied a Chinese family and revealed 5.4% and 3.2% fetal hemoglobin (HbF) with advantageously A␥ type in the mother and the daughter, respectively, using alkali denaturation assay and urea-Triton-acrylamide gel electrophoresis and high-performance liquid chromatography. The father's HbF was less than 0.5%. Large deletion was not observed within the -globin gene cluster by restriction endonulease mapping. Characterization by the polymerase chain reaction (PCR) and DNA sequencing demonstrated the mother is a homozygote with a novel four base-pair "AAGC" (-226 to -223) deletion within the A␥-globin gene promoter and the daughter is a heterozygote with this deletion. The deletion was not detected in the father. No any mutations were identified in the G␥ promoter of all the subjects studied. We propose that the small deletion is associated with the slight increase of A␥ gene expression in adult. Am.
📜 SIMILAR VOLUMES